Oppenheimer Maintains Veru Inc(VERU.US) With Buy Rating, Maintains Target Price $5

Oppenheimer analyst Leland Gershell maintains $Veru Inc(VERU.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 36.5% and a

Moomoo NewsJul 17 12:38 ET · Ratings

Express News | Veru Inc : Jefferies Cuts Target Price to $1 From $1.2

ReutersJul 17 11:26 ET

Express News | Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adults And Cancer Patients

BenzingaJun 24 08:39 ET

More Unpleasant Surprises Could Be In Store For Veru Inc.'s (NASDAQ:VERU) Shares After Tumbling 39%

Veru Inc. (NASDAQ:VERU) shares have retraced a considerable 39% in the last month, reversing a fair amount of their solid recent performance. Instead of being rewarded, shareholders who have alread

Simply Wall StJun 19 07:16 ET

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

Veru Inc. (NASDAQ: VERU) today announced that its Annual Meeting of Shareholders scheduled for today (Annual Meeting) was convened and adjourned without any business being conducted due to lack of a required quorum.

GlobeNewswireJun 18 16:05 ET

Russell 3000: Veru, Life MD Among Consumer Staple Additions; Benson Hill, PetMed Express Among Deletions

Seeking AlphaMay 30 17:29 ET